NYSE:OSCR
Oscar Health, Inc.
Oscar Health, Inc.'s revenue grew 27.5% in fiscal 2025 to $11.7B. Return on average equity was −44.5%, and the diluted share count fell 1.3%.Summary generated from Oscar Health, Inc.'s SEC filings. Latest annual report filed Feb 13, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$11.7B
Revenue growth+27.5%
Revenue, 5-yr CAGR+90.8%
Net margin−3.8%
Return on equity−44.5%
Share count change−1.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.8 | 4.0 | 5.9 | 9.2 | 11.7 |
| Net income | −0.6 | −0.6 | −0.3 | 0.0 | −0.4 |
Recent filings
- 4Insider transaction report
Sep 22, 2026 - 4Insider transaction report
Sep 18, 2026 - 8-KRegulation FD disclosure
Sep 16, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KResults of a shareholder vote
Jun 9, 2026 - 8-KRegulation FD disclosure
Jun 8, 2026 - 8-KDirector or officer change
Jun 2, 2026